Arican Pinar, Olgac Dundar Nihal, Ozyilmaz Berk, Cavusoglu Dilek, Gencpinar Pinar, Erdogan Kadri Murat, Saka Guvenc Merve
Department of Pediatric Neurology, Tepecik Training and Research Hospital, Izmir, Turkey.
Department of Pediatric Neurology, Katip Celebi University, Izmir, Turkey.
J Pediatr Genet. 2019 Mar;8(1):1-9. doi: 10.1055/s-0038-1676583. Epub 2018 Dec 14.
Chromosomal microarray (CMA) analysis for discovery of copy number variants (CNVs) is now recommended as a first-line diagnostic tool in patients with unexplained developmental delay/intellectual disability (DD/ID) and autism spectrum disorders. In this study, we present the results of CMA analysis in patients with DD/ID. Of 210 patients, pathogenic CNVs were detected in 26 (12%) and variants of uncertain clinical significance in 36 (17%) children. The diagnosis of well-recognized genetic syndromes was achieved in 12 patients. CMA analysis revealed pathogenic de novo CNVs, such as 11p13 duplication with new clinical features. Our results support the utility of CMA as a routine diagnostic test for unexplained DD/ID.
如今,染色体微阵列(CMA)分析用于发现拷贝数变异(CNV),已被推荐作为不明原因发育迟缓/智力残疾(DD/ID)和自闭症谱系障碍患者的一线诊断工具。在本研究中,我们展示了DD/ID患者CMA分析的结果。在210例患者中,26例(12%)检测到致病性CNV,36例(17%)儿童检测到临床意义不确定的变异。12例患者确诊为公认的遗传综合征。CMA分析揭示了致病性新发CNV,如具有新临床特征的11p13重复。我们的结果支持CMA作为不明原因DD/ID的常规诊断检测方法的实用性。